Use of granulocyte colony-stimulating factor in patients with severe sepsis or septic shock
Author:
Affiliation:
1. Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh (UP), and Internal Medicine Specialist, Department of Pharmacy, UP Medical Center, Pittsburgh, PA
Publisher
Oxford University Press (OUP)
Subject
Health Policy,Pharmacology
Link
http://academic.oup.com/ajhp/article-pdf/67/15/1238/28344653/ajhp1238.pdf
Reference51 articles.
1. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care;Angus;Crit Care Med,2001
2. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003;Dombrovskiy;Crit Care Med,2007
3. An audit of the use of granulocyte colony-stimulating factor in septic shock;Stephens;Intern Med J,2002
4. Physiology of granulocyte and macrophage colony-stimulating factors in host defense;Weisbart;Hematol Oncol Clin North Am,1989
5. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission;Weiss;Intensive Care Med,2003
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Decoding Sepsis-Induced Disseminated Intravascular Coagulation: A Comprehensive Review of Existing and Emerging Therapies;Journal of Clinical Medicine;2023-09-22
2. Emerging aspects of cytokine storm in COVID-19: The role of proinflammatory cytokines and therapeutic prospects;Cytokine;2023-09
3. Monocyte distribution width alterations and cytokine storm are modulated by circulating histones;Clinical Chemistry and Laboratory Medicine (CCLM);2023-02-28
4. The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver Failure;Seminars in Liver Disease;2021-05-15
5. Granulocyte Colony-Stimulating Factor Use in Decompensated Cirrhosis: Lack of Survival Benefit;Journal of Clinical and Experimental Hepatology;2020-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3